Deborah Brown
Lead, Strategic Partnerships
Expertise:
Deborah leads EVERSANA’s partnership expansion plans for the commercial business in Canada. Her career spans more than 30 years in marketing, regulatory, product planning and commercial leadership in Canada and the U.S. Prior to joining EVERSANA, Deborah was one of the founding partners of Accelera Canada Ltd. (healthcare consulting firm) and the president of EMD Serono Canada for 14 years, as well as the executive vice president of EMD Serono (US) for 4 years.
She has been awarded the Canadian Marketing Hall of Fame award, the BIOTECanada Gold Leaf Award and the Serono CEO’s 21st Century Award. She holds an MBA from Ivey Business School at Western University.
Articles by Deborah Brown
Q&A: Enhanced Protection and Consistency for PRCI in Canada
Introduction At EVERSANA, we’re at the forefront of regulatory work in Canada, and recently, our team has been delving into the realm of PRCI (Public Release of Clinical Information) in Canada and submission Policy 0070 (Regulation EMA (EU) 536/2014) in Europe). In a recent conversation, Deborah Brown, Lead, Strategic Partnerships, sheds light on the intricacies of this process, the technology behind it, and how it positions EVERSANA as a valuable partner for pharmaceutical companies. Let’s dive into the key takeaways from this insightful discussion. Understanding PCRI Question: What is PRCI, and Why Does it Matter? Deborah Brown: PRCI stands for Public Release of Clinical Information, a mandate in Canada. In […]
Unlocking Your Full North American Potential: Coordinating Launches in The U.S. and Canada
Discover the groundbreaking strategy that could redefine pharmaceutical launches and propel your product’s success across North America. In the realm of pharmaceutical launches, a paradigm shift is underway, challenging the conventional sequential approach and calling for a bolder strategy that reaps unparalleled benefits. “Unlocking Your Full North American Potential: Coordinating Launches in The U.S. and Canada” presents a revolutionary perspective on launch synchronization, dispelling myths and highlighting the untapped potential of a united North American launch. Authored by industry thought leaders Deborah Brown, Ryan H. Brown, Kerem Can Alp, Adam Hardy, and Charles Pirraglia, this paper unveils the transformative potential of parallel launches in the U.S. and Canada. Departing from […]
How to Ensure Speed and Efficiency When Launching in Canada
Today is an extraordinary time for medical innovation. The pharmaceutical industry is yielding protection against diseases, focusing more on rare and complex disease treatments, and the world is getting better health outcomes. Global life expectancy is more than 70% higher today than it was in 1960 as diseases that were once considered terminal are now treatable. Why Canada? As one of the world’s top 10 pharmaceutical markets and home to some of the highest per capita healthcare spending on the globe, Canada should be a strategic priority for pharmaceutical manufacturers. That’s why EVERSANA provides a unique set of offerings tailored to support our global clients as they navigate Canada’s pharmaceutical […]